Spruce Biosciences to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
SAN FRANCISCO–(BUSINESS WIRE)–$SPRB #Tildacerfont—Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet medical need, today announced that Samir Gharib, President and Chief Financial Officer, will present at the H.C. Wainwright 24th Annual Global Investment Conference on September 12, 2022 at 5:00 … [Read more…]
